The Oncidium foundation : support and enhance the development of radiotheranostics for cancer care.
The Oncidium foundation is dedicated to supporting the development of radiotheranostics (RLT) for cancer care. It strives to connect patients, practitioners & experts in the Nuc. Med. field by raising awareness & improving access to cancer treatments & clinical trials worldwide.
Our projects are based on 3 pillars:
ACCESS – Through a platform that will create cohesion between all interlocutors. Notably, for patients, to find the nearest treatment center, clinical trials and to facilitate communication with medical experts; For practitioners to register their therapy centers; For RLT experts to help promote precision medicine & its progress. Thus, bridging the gap between people to advance the availability of this innovative & life-saving technology.
EDUCATION – Education & awareness are essential, as they help bring a better understanding of the functioning & benefits of RLT, still unknown to some practitioners & the general public.
HOPE – When other cures are not an option. The foundation is evaluating all possibilities to support clinical developments of efficient RLT & individual cases to reduce treatment overall costs in low-income countries. Moreover, Oncidium endeavors beyond borders through a worldwide network of Ambassadors in each country for awareness & education campaigns, local collaborations & shared.